Cargando…

Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis

BACKGROUND: Tuberculosis (TB) preventive therapy (TPT) is an essential component of care for people living with HIV (PLHIV). We compared efficacy, safety, completion, and drug-resistant TB risk for currently recommended TPT regimens through a systematic review and network meta-analysis (NMA) of rand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yanes-Lane, Mercedes, Ortiz-Brizuela, Edgar, Campbell, Jonathon R., Benedetti, Andrea, Churchyard, Gavin, Oxlade, Olivia, Menzies, Dick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439495/ https://www.ncbi.nlm.nih.gov/pubmed/34520459 http://dx.doi.org/10.1371/journal.pmed.1003738

Ejemplares similares

Tuberculosis preventive treatment in people living with HIV—Is the glass half empty or half full?
por: Oxlade, Olivia, et al.
Publicado: (2021)

Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis
por: Uppal, Aashna, et al.
Publicado: (2021)

The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis
por: Bastos, Mayara Lisboa, et al.
Publicado: (2021)

Effects of programmatic interventions to improve the management of latent tuberculosis: a follow up study up to five months after implementation
por: Yanes-Lane, Mercedes, et al.
Publicado: (2021)

The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study
por: Romanowski, Kamila, et al.
Publicado: (2019)

Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis
por: Vesga, Juan F., et al.
Publicado: (2022)

Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis
por: Bastos, Mayara Lisboa, et al.
Publicado: (2022)

Modeling the impact of tuberculosis interventions on epidemiologic outcomes and health system costs
por: Oxlade, Olivia, et al.
Publicado: (2015)

New opportunities in tuberculosis prevention: implications for people living with HIV
por: González Fernández, Lucia, et al.
Publicado: (2020)

Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
por: Tseng, Chia-Lin, et al.
Publicado: (2011)

Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis
por: Yanes-Lane, Mercedes, et al.
Publicado: (2020)

Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti
por: Jacquet, Vary, et al.
Publicado: (2006)

What’s Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2019)

How Methodologic Differences Affect Results of Economic Analyses: A Systematic Review of Interferon Gamma Release Assays for the Diagnosis of LTBI
por: Oxlade, Olivia, et al.
Publicado: (2013)

Patients' Costs and Cost-Effectiveness of Tuberculosis Treatment in DOTS and Non-DOTS Facilities in Rio de Janeiro, Brazil
por: Steffen, Ricardo, et al.
Publicado: (2010)

Plasma host protein biomarkers correlating with increasing Mycobacterium tuberculosis infection activity prior to tuberculosis diagnosis in people living with HIV
por: Singer, Sarah N., et al.
Publicado: (2021)

Acceptability, feasibility, and impact of a pilot tuberculosis literacy and treatment counselling intervention: a mixed methods study
por: Law, Stephanie, et al.
Publicado: (2021)

Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis
por: Campbell, Jonathon R, et al.
Publicado: (2020)

Cost‐effectiveness of a 12 country‐intervention to scale up short course TB preventive therapy among people living with HIV
por: Shin, Hyejeong, et al.
Publicado: (2020)

Assessing the Diagnostic Performance of New Commercial Interferon-γ Release Assays for Mycobacterium tuberculosis Infection: A Systematic Review and Meta-Analysis
por: Ortiz-Brizuela, Edgar, et al.
Publicado: (2023)

Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2022)

Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis
por: Roscoe, Clay, et al.
Publicado: (2020)

Solutions to improve the latent tuberculosis Cascade of Care in Ghana: a longitudinal impact assessment
por: Barss, Leila, et al.
Publicado: (2020)

Triage of Persons With Tuberculosis Symptoms Using Artificial Intelligence–Based Chest Radiograph Interpretation: A Cost-Effectiveness Analysis
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2021)

Cost‐effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda
por: Ferguson, Olivia, et al.
Publicado: (2020)

Tuberculosis and Poverty: Why Are the Poor at Greater Risk in India?
por: Oxlade, Olivia, et al.
Publicado: (2012)

WHO target product profiles for TB preventive treatment
por: Den Boon, S., et al.
Publicado: (2022)

Framework for the evaluation of new tests for tuberculosis infection
por: Hamada, Yohhei, et al.
Publicado: (2021)

Acceptability of Community-Based Tuberculosis Preventive Treatment for People Living with HIV in Zimbabwe
por: Msukwa, Martin K., et al.
Publicado: (2022)

Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV
por: Vojnov, Lara, et al.
Publicado: (2022)

Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis
por: Auld, Sara C., et al.
Publicado: (2021)

Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis
por: Ryckman, Theresa, et al.
Publicado: (2023)

Tuberculosis control in people living with HIV/AIDS
por: Magnabosco, Gabriela Tavares, et al.
Publicado: (2016)

Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial
por: Oxlade, Olivia, et al.
Publicado: (2019)

GeneXpert or chest-X-ray or tuberculin skin testing for household contact assessment (GXT): protocol for a cluster-randomized trial
por: Trajman, Anete, et al.
Publicado: (2022)

Tuberculosis Prevention in South Africa
por: Knight, Gwenan M., et al.
Publicado: (2015)

The mTST – An mHealth approach for training and quality assurance of tuberculin skin test administration and reading
por: Moayedi-Nia, Saeedeh, et al.
Publicado: (2019)

The potential impact and cost-effectiveness of tobacco reduction strategies for tuberculosis prevention in Canadian Inuit communities
por: N’Diaye, Dieynaba S., et al.
Publicado: (2019)

Patient costs incurred by people living with HIV/AIDS prior to ART initiation in primary healthcare facilities in Gauteng, South Africa
por: Pillai, Natasha, et al.
Publicado: (2019)

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dr47fgo3dc40jdldjlg2cbhmrj